Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist
Consortia: CTAR
Damond N, Thorel F, Moyers JS, Charron MJ, Vuguin PM, Powers AC, Herrera PL.
eLIFE. http://dx.doi.org/10.7554/eLife.13828
Consortia: CTAR
Damond N, Thorel F, Moyers JS, Charron MJ, Vuguin PM, Powers AC, Herrera PL.
eLIFE. http://dx.doi.org/10.7554/eLife.13828